Danish-based Novo Holdings A/S, a wholly-owned subsidiary of the Novo Nordisk Foundation.
Location
Hellerup, Capital Region of Denmark, DK
Founded
1999
Novo Holdings A/S, based in Denmark, is the holding and investment company of the Novo Nordisk Foundation. The firm manages a diverse investment portfolio with a long-term return perspective, focusing on various stages including Series A, B, C, D, and beyond. Novo Holdings is the controlling shareholder of Novo Nordisk and Novozymes and invests across multiple sectors, primarily in life sciences and healthcare.
Notable portfolio companies include Akebia Therapeutics, Aligos Therapeutics, and Tempus Labs. Key partners and decision-makers leverage their extensive industry experience to guide investments. Novo Holdings is known for its strategic support and value-add services to portfolio companies, including leveraging its deep industry connections and expertise to foster growth and innovation.
Novo Holdings - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
